The hemoglobin content in reticulocytes (equivalent to the MCH in red cells) serves as an indicator of iron deficiency. The measurement of reticulocyte hemoglobin content is particularly useful in chronic renal dialysis patients who are anemic, as this can help decide whether to administer iron and/or erythropoietin. It is also useful in monitoring response to iron therapy.